Exploring Brain Damages After COVID-19 Infection
BRAINCOV
1 other identifier
interventional
38
1 country
1
Brief Summary
Although direct evidence is currently lacking, the high identity between SARS-CoV-1 and SARS-CoV-2 suggests, that the latter viral strain could also infect the Central Nervous System (CNS). Indeed, some cases of SARS-COV2 encephalitis begin to be described and CNS damages are increasingly highlighted in the literature, but still not objectified by imaging and do not allow to explain the entire clinical patterns. We hypothesise that these CNS damages are not always objectified by Magnetic Resonance Imaging (MRI) but could be indirectly observed by a physiological dysfunction of neural conduction in the brainstem. We will explore brainstem disruption through an electrophysiological approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2020
CompletedStudy Start
First participant enrolled
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
May 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2021
CompletedApril 8, 2021
April 1, 2021
10 months
May 8, 2020
April 7, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Latency of electrophysiological response
Latencies of electrophysiological responses with Auditory Evoked Potentials
Inclusion (T0)
Delay of Muscle contraction
Delay of Muscle contraction (Blink reflex)
Inclusion (T0)
Delay of silent period
Delay of silent period while the patient is asked to tighten the jaws (Masseter Inhibitory Reflex)
Inclusion (T0)
Duration of silent period
Duration of silent period while the patient is asked to tighten the jaws (Masseter Inhibitory Reflex)
Inclusion (T0)
Inhibition rate
Inhibition rate while the patient is asked to tighten the jaws (Masseter Inhibitory Reflex)
Inclusion (T0)
Study Arms (1)
Electrophysiological procedure
EXPERIMENTALBrainstem reflexes and neural conduction will be explored using Auditory Evoked Potentials (AEP) and blink and Masseter Inhibitory Reflex (MIR) in hospitalised patients with COVID infection
Interventions
Record of electrophysiological responses (Auditory Evoked Potentials or AEP) during auditory stimulations with an electroencephalogram (EEG).
Electrophysiological exploration while stimulating trigeminal nerve to record 1) motor response induced (muscle contraction delay (Blink)) of the facial nerve, or 2) the contraction inhibition of masseters (Masseter Inhibitory Reflex (MIR)).
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Hospitalized patient suffering from a positive COVID 19 diagnosed by Reverse transcription polymerase chain reaction (RT-PCR) or chest computed tomography scan (CTscan) with specific lesions
You may not qualify if:
- History of neurological damage interfering with auditory evoked potentials (PEA) and Electromyography (EMG) reflexes of the brainstem (stroke of the brainstem, acoustic neuroma, amyotrophic lateral sclerosis, facial diplegia, damage to nerves V or VII, etc.)
- Impaired alertness
- Sedative treatments or treatments that disturb nerve conduction.
- Pregnancy or breastfeeding
- Individuals under legal protection or unable to express personally their consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux
Bordeaux, 33 076, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bertrand Glize
bertrand.glize@chu-bordeaux.fr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2020
First Posted
May 28, 2020
Study Start
May 19, 2020
Primary Completion
March 10, 2021
Study Completion
March 10, 2021
Last Updated
April 8, 2021
Record last verified: 2021-04